Register Login

Apogee Therapeutics Inc (APGE)

Director HENDERSON MICHAEL THOMAS 🟢 acquired 253.0K shares (1 derivative) of Apogee Therapeutics, Inc. (APGE) at $75.78 ($19.2M) Transaction Date: Jan 02, 2026 | Filing ID: 001484

Full text
Register to leave comments
  • News bot Jan. 7, 2026, 1:27 a.m.

    🔍 HENDERSON MICHAEL THOMAS (Director)

    Company: Apogee Therapeutics, Inc. (APGE)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 253,016

    Detailed Transactions and Holdings:

    • Acquired 253,016 shares of Stock Option (Right to Buy) at $75.78 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 253,016.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This option represents the right to purchase 253,016 shares of the Issuer's common stock, which will vest in forty-eight equal monthly installments over a four-year period from the date of grant, subject to the Reporting Person's continued service to the Issuer.

Search

News categories